Item 7.01 Regulation FD Disclosure.
In advance of its scheduled presentation at the
In addition, due to continued strong demand for its high-performance life
science tools, scientific instruments, and diagnostic solutions, the Company now
expects its non-GAAP organic revenue growth for fiscal year 2021 to be in a
range of 13% to 15% compared to the fiscal year ended
The anticipated financial results referred to herein are based on management's
preliminary, unaudited analysis of its financial performance as of the date
hereof. As of the date hereof, the fiscal quarter ending
The information furnished in this Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Use of Non-GAAP Financial Measures
We refer in this Current Report on Form 8-K to anticipated organic revenue growth, a non-GAAP financial measure. We define the term organic revenue as GAAP revenue excluding the effect of changes in foreign currency translation rates and the effect of acquisitions and divestitures, and believe it is a useful measure to evaluate our continuing business.
The presentation of non-GAAP financial measures is not intended to be a substitute for, or superior to, financial information prepared and presented in accordance with GAAP and may be different from non-GAAP financial measures used by other companies, and therefore, may not be comparable among companies. We believe this non-GAAP financial measure provides meaningful supplemental information regarding our performance, however we urge investors not to rely on any single financial measure to evaluate our business. Specifically, management believes that the non-GAAP organic revenue growth provides relevant and useful information which is widely used by analysts, investors and competitors in our industry, as well as by our management, in assessing both consolidated and business unit performance.
We use this and other non-GAAP financial measures to evaluate our period-over-period operating performance because our management believes this provides a more comparable measure of our continuing business by adjusting for certain items that are not reflective of the underlying performance of our business. This measure may also be useful to investors in evaluating the underlying operating performance of our business and forecasting future results. We regularly use non-GAAP financial measures internally to understand, manage, and evaluate our business results and make operating decisions. We also measure our employees and compensate them, in part, based on certain non-GAAP measures and use this information for our planning and forecasting activities.
For the Company's outlook for the fiscal quarter ending
--------------------------------------------------------------------------------
Forward Looking Statements
Any statements contained in this Current Report on Form 8-K that do not describe
historical facts may constitute forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, including statements regarding
management's current expectations with respect to our anticipated second quarter
2021 and anticipated full year 2021 performance, including our non-GAAP organic
revenue growth. Any forward-looking statements contained herein are based on
current expectations, but are subject to risks and uncertainties that could
cause actual results to differ materially from those indicated, including, but
not limited to, risks and uncertainties relating to the preliminary nature of
the Company's second quarter 2021 financial information, which is subject to
completion of the quarter and of the quarterly review procedures, risks related
to the global economy and the COVID-19 pandemic, and other risk factors
discussed from time to time in our filings with the
--------------------------------------------------------------------------------
© Edgar Online, source